v3.24.2
Condensed Consolidated Balance Sheets - USD ($)
shares in Millions, $ in Millions
Jun. 30, 2024
Dec. 31, 2023
ASSETS    
Cash and equivalents $ 505 $ 515
Restricted cash 3 3
Accounts receivable, net 695 666
Inventories, net 311 298
Other current assets 127 134
Total current assets 1,641 1,616
Property and equipment, net 416 418
Intangible assets, net 84 90
Right-of-use assets 111 109
Investments in non-consolidated affiliates 25 35
Other non-current assets 83 75
Total assets 2,731 2,727
LIABILITIES AND EQUITY    
Short-term debt 18 18
Accounts payable 529 551
Accrued employee liabilities 81 99
Current lease liability 31 30
Other current liabilities 228 233
Total current liabilities 887 931
Long-term debt, net 309 318
Employee benefits 149 160
Non-current lease liability 83 79
Deferred tax liabilities 34 31
Other non-current liabilities 71 85
Stockholders’ equity:    
Preferred stock (par value 0.01, 50 million shares authorized, none outstanding as of June 30, 2024 and December 31, 2023) $ 0 0
Common stock, shares, issued (in shares) 55  
Common stock, shares authorized (in shares) 250  
Common stock, par value (in dollars per share) $ 0.01  
Common stock (par value $0.01, 250 million shares authorized, 55 million shares issued, 27600000 million shares outstanding as of June 30, 2024 and 27.7 million shares outstanding as of December 31, 2023) $ 1 1
Additional paid-in capital 1,360 1,356
Retained earnings 2,387 2,274
Accumulated other comprehensive loss (286) (254)
Treasury stock (2,349) (2,339)
Total Visteon Corporation stockholders’ equity 1,113 1,038
Non-controlling interests 85 85
Total equity 1,198 1,123
Total liabilities and equity 2,731 2,727
Deferred Tax Assets, Tax Deferred Expense $ 371 $ 384